Show simple item record

dc.contributor.authorLitchfield, K
dc.contributor.authorLevy, M
dc.contributor.authorOrlando, G
dc.contributor.authorLoveday, C
dc.contributor.authorLaw, PJ
dc.contributor.authorMigliorini, G
dc.contributor.authorHolroyd, A
dc.contributor.authorBroderick, P
dc.contributor.authorKarlsson, R
dc.contributor.authorHaugen, TB
dc.contributor.authorKristiansen, W
dc.contributor.authorNsengimana, J
dc.contributor.authorFenwick, K
dc.contributor.authorAssiotis, I
dc.contributor.authorKote-Jarai, Z
dc.contributor.authorDunning, AM
dc.contributor.authorMuir, K
dc.contributor.authorPeto, J
dc.contributor.authorEeles, R
dc.contributor.authorEaston, DF
dc.contributor.authorDudakia, D
dc.contributor.authorOrr, N
dc.contributor.authorPashayan, N
dc.contributor.authorUK Testicular Cancer Collaboration,
dc.contributor.authorPRACTICAL Consortium,
dc.contributor.authorBishop, DT
dc.contributor.authorReid, A
dc.contributor.authorHuddart, RA
dc.contributor.authorShipley, J
dc.contributor.authorGrotmol, T
dc.contributor.authorWiklund, F
dc.contributor.authorHoulston, RS
dc.contributor.authorTurnbull, C
dc.date.accessioned2017-07-20T09:46:25Z
dc.date.issued2017-07-01
dc.identifier.citationNature genetics, 2017, 49 (7), pp. 1133 - 1140
dc.identifier.issn1061-4036
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/732
dc.identifier.eissn1546-1718
dc.identifier.doi10.1038/ng.3896
dc.description.abstractGenome-wide association studies (GWAS) have transformed understanding of susceptibility to testicular germ cell tumors (TGCTs), but much of the heritability remains unexplained. Here we report a new GWAS, a meta-analysis with previous GWAS and a replication series, totaling 7,319 TGCT cases and 23,082 controls. We identify 19 new TGCT risk loci, roughly doubling the number of known TGCT risk loci to 44. By performing in situ Hi-C in TGCT cells, we provide evidence for a network of physical interactions among all 44 TGCT risk SNPs and candidate causal genes. Our findings implicate widespread disruption of developmental transcriptional regulators as a basis of TGCT susceptibility, consistent with failed primordial germ cell differentiation as an initiating step in oncogenesis. Defective microtubule assembly and dysregulation of KIT-MAPK signaling also feature as recurrently disrupted pathways. Our findings support a polygenic model of risk and provide insight into the biological basis of TGCT.
dc.formatPrint-Electronic
dc.format.extent1133 - 1140
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectUK Testicular Cancer Collaboration
dc.subjectPRACTICAL Consortium
dc.subjectChromatin
dc.subjectHumans
dc.subjectNeoplasms, Germ Cell and Embryonal
dc.subjectTesticular Neoplasms
dc.subjectGenetic Predisposition to Disease
dc.subjectRisk
dc.subjectGene Expression Profiling
dc.subjectGenotype
dc.subjectPolymorphism, Single Nucleotide
dc.subjectAdult
dc.subjectMiddle Aged
dc.subjectMale
dc.subjectGenome-Wide Association Study
dc.subjectYoung Adult
dc.subjectMolecular Sequence Annotation
dc.titleIdentification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor.
dc.typeJournal Article
dcterms.dateAccepted2017-05-16
rioxxterms.versionofrecord10.1038/ng.3896
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-07
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfNature genetics
pubs.issue7
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Complex Trait Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular & Population Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Complex Trait Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular & Population Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Sarcoma Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume49
pubs.embargo.termsNot known
icr.researchteamComplex Trait Genetics
icr.researchteamCancer Genomics
icr.researchteamMolecular & Population Genetics
icr.researchteamSarcoma Molecular Pathology
icr.researchteamClinical Academic Radiotherapy (Huddart)
icr.researchteamOncogenetics
dc.contributor.icrauthorLitchfield, Kevin
dc.contributor.icrauthorLaw, Philip
dc.contributor.icrauthorBroderick, Peter
dc.contributor.icrauthorKote-Jarai, Zsofia
dc.contributor.icrauthorEeles, Rosalind
dc.contributor.icrauthorHuddart, Robert
dc.contributor.icrauthorShipley, Janet
dc.contributor.icrauthorHoulston, Richard
dc.contributor.icrauthorTurnbull, Clare


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record